This Web site is developed and maintained under the editorial direction of diagnosticimaging.com, the Web site of Diagnostic Imaging magazine and its related publications.
It is the goal of this Web site to be the Web’s most comprehensive and up-to-date source of information on radiofrequency ablation and other energy-based tumor ablation therapies.
Material for this site is developed by physicians and medical journalists. Material also comes from the pages of Diagnostic Imaging magazine and its related publications, from Oncology News International magazine, and from reports published at www.diagnosticimaging.com.
Editorial director:
John C. Hayes, john.hayes@cmpmedica.com
Contributing editors:
Sarah Jersild, sjersild@gmail.com
H.A. Abella, habella@cmp.com
Copy editors:
Kathleen Lawrence
Frances Taylor
Web Master:
DIWebMaster@cmp.comEditorial questions: Inquiries should be directed to the Editor, Diagnostic Imaging, 600 Harrison St., San Francisco, CA 94107, 415/947-6472, john.hayes@cmpmedica.com.
DISCLOSURE: The editorial material on this Web site is published solely by CMP Healthcare Media Group LLC, the publisher of Diagnostic Imaging. CMP Media LLC does not endorse the appropriateness of or are responsible for any actions taken by third parties on the basis of material available at this Web site.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.